Viewing Study NCT05501561


Ignite Creation Date: 2025-12-24 @ 12:01 PM
Ignite Modification Date: 2025-12-27 @ 9:30 PM
Study NCT ID: NCT05501561
Status: COMPLETED
Last Update Posted: 2024-04-03
First Post: 2022-08-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age
Sponsor: Seqirus
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module